Cargando…

Prokaryotic expression of antibodies and affibodies

Recent advances have been made in the development of systems for the display and expression of recombinant antibodies and affibodies in filamentous phages, Escherichia coli and other prokaryotic cells. Emphasis has been placed on improving phage and phagemid vectors, alternative systems for expressi...

Descripción completa

Detalles Bibliográficos
Autor principal: Fernández, Luis Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172615/
https://www.ncbi.nlm.nih.gov/pubmed/15296932
http://dx.doi.org/10.1016/j.copbio.2004.06.004
_version_ 1783524288825917440
author Fernández, Luis Angel
author_facet Fernández, Luis Angel
author_sort Fernández, Luis Angel
collection PubMed
description Recent advances have been made in the development of systems for the display and expression of recombinant antibodies and affibodies in filamentous phages, Escherichia coli and other prokaryotic cells. Emphasis has been placed on improving phage and phagemid vectors, alternative systems for expression in different cellular compartments (e.g. the outer membrane, periplasm, cytoplasm and extracellular secretion) and novel multimerization systems for generating bivalent or multivalent binding molecules.
format Online
Article
Text
id pubmed-7172615
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71726152020-04-22 Prokaryotic expression of antibodies and affibodies Fernández, Luis Angel Curr Opin Biotechnol Article Recent advances have been made in the development of systems for the display and expression of recombinant antibodies and affibodies in filamentous phages, Escherichia coli and other prokaryotic cells. Emphasis has been placed on improving phage and phagemid vectors, alternative systems for expression in different cellular compartments (e.g. the outer membrane, periplasm, cytoplasm and extracellular secretion) and novel multimerization systems for generating bivalent or multivalent binding molecules. Elsevier Ltd. 2004-08 2004-06-22 /pmc/articles/PMC7172615/ /pubmed/15296932 http://dx.doi.org/10.1016/j.copbio.2004.06.004 Text en Copyright © 2004 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Fernández, Luis Angel
Prokaryotic expression of antibodies and affibodies
title Prokaryotic expression of antibodies and affibodies
title_full Prokaryotic expression of antibodies and affibodies
title_fullStr Prokaryotic expression of antibodies and affibodies
title_full_unstemmed Prokaryotic expression of antibodies and affibodies
title_short Prokaryotic expression of antibodies and affibodies
title_sort prokaryotic expression of antibodies and affibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172615/
https://www.ncbi.nlm.nih.gov/pubmed/15296932
http://dx.doi.org/10.1016/j.copbio.2004.06.004
work_keys_str_mv AT fernandezluisangel prokaryoticexpressionofantibodiesandaffibodies